4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041307
10% owner bought 118,750 shares at $16.00 ($1,900,000)
- 10% owner acquired 441,071 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 6 Dimensions Capital, L.P. 10% owner | 2019-07-22 | Conversion | +441,071 | 441,071 | D: show line 1 in the form | ||
| 6 Dimensions Capital, L.P. 10% owner | 2019-07-22 | Purchase | +118,750 | $16.00 | $1,900,000 | 559,821 | D: show line 2 in the form |
| Open-market purchases · 118,750 sh · avg $16.00 · $1,900,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Dimensions Capital, L.P. 10% owner | 2019-07-22 | Conversion · Series B Preferred Stock | −3,087,500 | 0 | D: show line 3 in the form |
Loading xslF345X03/a4.xml…